PLUS · Eplus Inc · Insider Trading

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025.

The transaction was executed in multiple trades at prices ranging from $96.23 to $97.15 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased and prices at which the transaction was effected.

The shares are held in a revocable trust, of which the reporting person and her spouse are the sole trustees and beneficiaries.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025.

The transaction was executed in multiple trades at prices ranging from $95.21 to $96.18 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased and prices at which the transaction was effected.

The shares are held in a revocable trust, of which the reporting person and her spouse are the sole trustees and beneficiaries.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025.

The transaction was executed in multiple trades at prices ranging from $97.33 to $97.47 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased and prices at which the transaction was effected.

The shares are held in a revocable trust, of which the reporting person and her spouse are the sole trustees and beneficiaries.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025.

The transaction was executed in multiple trades at prices ranging from $95.00 to $95.06 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased and prices at which the transaction was effected.

The shares are held in a revocable trust, of which the reporting person and her spouse are the sole trustees and beneficiaries.

This restricted stock award consists of shares of common stock of the Company (the "Restricted Shares"). The Restricted Shares were granted pursuant to the Company's 2024 Non-Employee Director Long Term Incentive Plan (the "Plan") and are subject to a Restriction Period beginning on the grant date and ending on the first anniversary of the grant; or, if earlier than the first anniversary of the grant, on the date of the Company's annual stockholder meeting that next follows after the date that the Award was granted.

This restricted stock award consists of shares of common stock of the Company (the "Restricted Shares"). The Restricted Shares were granted pursuant to the Company's 2024 Non-Employee Director Long Term Incentive Plan (the "Plan") and are subject to a Restriction Period beginning on the grant date and ending on the first anniversary of the grant; or, if earlier than the first anniversary of the grant, on the date of the Company's annual stockholder meeting that next follows after the date that the Award was granted.

This restricted stock award consists of shares of common stock of the Company (the "Restricted Shares"). The Restricted Shares were granted pursuant to the Company's 2024 Non-Employee Director Long Term Incentive Plan (the "Plan") and are subject to a Restriction Period beginning on the grant date and ending on the first anniversary of the grant; or, if earlier than the first anniversary of the grant, on the date of the Company's annual stockholder meeting that next follows after the date that the Award was granted.

This restricted stock award consists of shares of common stock of the Company (the "Restricted Shares"). The Restricted Shares were granted pursuant to the Company's 2024 Non-Employee Director Long Term Incentive Plan (the "Plan") and are subject to a Restriction Period beginning on the grant date and ending on the first anniversary of the grant; or, if earlier than the first anniversary of the grant, on the date of the Company's annual stockholder meeting that next follows after the date that the Award was granted.

This restricted stock award consists of shares of common stock of the Company (the "Restricted Shares"). The Restricted Shares were granted pursuant to the Company's 2024 Non-Employee Director Long Term Incentive Plan (the "Plan") and are subject to a Restriction Period beginning on the grant date and ending on the first anniversary of the grant; or, if earlier than the first anniversary of the grant, on the date of the Company's annual stockholder meeting that next follows after the date that the Award was granted.

This restricted stock award consists of shares of common stock of the Company (the "Restricted Shares"). The Restricted Shares were granted pursuant to the Company's 2024 Non-Employee Director Long Term Incentive Plan (the "Plan") and are subject to a Restriction Period beginning on the grant date and ending on the first anniversary of the grant; or, if earlier than the first anniversary of the grant, on the date of the Company's annual stockholder meeting that next follows after the date that the Award was granted.

This restricted stock award consists of shares of common stock of the Company (the "Restricted Shares"). The Restricted Shares were granted pursuant to the Company's 2024 Non-Employee Director Long Term Incentive Plan (the "Plan") and are subject to a Restriction Period beginning on the grant date and ending on the first anniversary of the grant; or, if earlier than the first anniversary of the grant, on the date of the Company's annual stockholder meeting that next follows after the date that the Award was granted.

On October 1, 2026, the reporting person was issued 232 shares of common stock (the "Shares"). The Shares were issued pursuant to the reporting person's election to receive the Shares in lieu of cash compensation as permitted under the ePlus' 2024 Non-Employee Director Long Term Incentive Plan.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.

The transaction was executed in multiple trades at prices ranging from $93.00 to $93.03 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased and prices at which the transaction was effected.

The shares are held in a revocable trust, of which the reporting person and his spouse are the sole trustees and beneficiaries.

This restricted stock award consists of shares of common stock of the Company (the "Restricted Shares"). The Restricted Shares were granted pursuant to the Company's 2024 Non-Employee Director Long Term Incentive Plan (the "Plan") and are subject to a Restriction Period beginning on the grant date and ending on the first anniversary of the grant; or, if earlier than the first anniversary of the grant, on the date of the Company's annual stockholder meeting that next follows after the date that the Award was granted.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.

The shares are held in a revocable trust, of which the reporting person and his spouse are the sole trustees and beneficiaries.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.

The transaction was executed in multiple trades at prices ranging from $93.00 to $93.99 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased and prices at which the transaction was effected.

The shares are held in a revocable trust, of which the reporting person and his spouse are the sole trustees and beneficiaries.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.

The transaction was executed in multiple trades at prices ranging from $94.01 to $94.08 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased and prices at which the transaction was effected.

The shares are held in a revocable trust, of which the reporting person and his spouse are the sole trustees and beneficiaries.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.

The transaction was executed in multiple trades at prices ranging from $93.00 to $93.60 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased and prices at which the transaction was effected.

The shares are held in a revocable trust, of which the reporting person and his spouse are the sole trustees and beneficiaries.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.

The transaction was executed in multiple trades at prices ranging from $93.01 to $93.34 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased and prices at which the transaction was effected.

The shares are held in a revocable trust, of which the reporting person and his spouse are the sole trustees and beneficiaries.

The transaction was executed in multiple trades at prices ranging from $87.85 to $88.63 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased and prices at which the transaction was effected.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.

The transaction was executed in multiple trades at prices ranging from $89.91 to $90.89 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased and prices at which the transaction was effected.

The shares are held in a revocable trust, of which the reporting person and his spouse are the sole trustees and beneficiaries.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.

The transaction was executed in multiple trades at prices ranging from $90.91 to $91.42 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased and prices at which the transaction was effected.

The shares are held in a revocable trust, of which the reporting person and his spouse are the sole trustees and beneficiaries.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.

The shares are held in a revocable trust, of which the reporting person and his spouse are the sole trustees and beneficiaries.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025.

The transaction was executed in multiple trades at prices ranging from $95.00 to $95.91 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased and prices at which the transaction was effected.

The shares are held in a revocable trust, of which the reporting person and her spouse are the sole trustees and beneficiaries.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025.

The transaction was executed in multiple trades at prices ranging from $96.07 to $97.02 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased and prices at which the transaction was effected.

The shares are held in a revocable trust, of which the reporting person and her spouse are the sole trustees and beneficiaries.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025.

The transaction was executed in multiple trades at prices ranging from $97.07 to $97.91 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased and prices at which the transaction was effected.

The shares are held in a revocable trust, of which the reporting person and her spouse are the sole trustees and beneficiaries.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025.

The transaction was executed in multiple trades at prices ranging from $95.00 to $95.32 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased and prices at which the transaction was effected.

The shares are held in a revocable trust, of which the reporting person and her spouse are the sole trustees and beneficiaries.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025.

The transaction was executed in multiple trades at prices ranging from $95.00 to $95.56 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased and prices at which the transaction was effected.

The shares are held in a revocable trust, of which the reporting person and her spouse are the sole trustees and beneficiaries.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025.

The transaction was executed in multiple trades at prices ranging from $95.00 to $95.56 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased and prices at which the transaction was effected.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.

The transaction was executed in multiple trades at prices ranging from $94.00 to $94.84 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased and prices at which the transaction was effected.

The shares are held in a revocable trust, of which the reporting person and his spouse are the sole trustees and beneficiaries.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.

The transaction was executed in multiple trades at prices ranging from $95.01 to $95.45 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased and prices at which the transaction was effected.

The shares are held in a revocable trust, of which the reporting person and his spouse are the sole trustees and beneficiaries.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.

The transaction was executed in multiple trades at prices ranging from $93.00 to $93.96 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased and prices at which the transaction was effected.

The shares are held in a revocable trust, of which the reporting person and his spouse are the sole trustees and beneficiaries.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.

The shares are held in a revocable trust, of which the reporting person and his spouse are the sole trustees and beneficiaries.

On July 6, 2026, Mr. Lutz, a newly appointed director of ePlus inc. (the "Company") was granted a restricted stock award consisting of 309 shares of common stock of the Company (the "Restricted Shares"). The Restricted Shares were granted pursuant to the Company's 2024 Non-Employee Director Long Term Incentive Plan (the "Plan") and are subject to a Restriction Period that ends on the earlier of October 1, 2026, or the date of the Company's annual stockholder meeting that next follows after the date that the Award was granted (the "Restriction Period"). As more fully described in the Plan, under certain other circumstances the restrictions may lapse, or the shares may be forfeited and transferred back to the Company.

On July 2, 2026, the reporting person transferred 25,562 shares of ePlus inc. common stock from an account owned by the reporting person to the Mark P. Marron Trust for no consideration. The reporting person remains the beneficial owner of the securities held by the trust.

On July 2, 2026, the reporting person transferred 25,562 shares of ePlus inc. common stock from an account owned by the reporting person to the Mark P. Marron Trust for no consideration. The reporting person remains the beneficial owner of the securities held by the trust.

The shares are held in a revocable trust, of which the reporting person and his spouse are the sole trustees and beneficiaries.

On July 2, 2026, the reporting person transferred 792 shares of ePlus inc. common stock from an account owned by the reporting person to the Bruce M. Bowen Trust for no consideration. The reporting person remains the beneficial owner of the securities held by the trust.

On July 2, 2026, the reporting person transferred 15,488 shares of ePlus inc. common stock from an account owned by the reporting person to the Darren S. Raiguel Trust for no consideration. The reporting person remains the beneficial owner of the securities held by the trust.

On July 2, 2026, the reporting person transferred 15,214 shares of ePlus inc. common stock from an account owned by the reporting person to the Elaine D. Marion Trust for no consideration. The reporting person remains the beneficial owner of the securities held by the trust.

On July 2, 2026, the reporting person transferred 792 shares of ePlus inc. common stock from an account owned by the reporting person to the Bruce M. Bowen Trust for no consideration. The reporting person remains the beneficial owner of the securities held by the trust.

On July 2, 2026, the reporting person transferred 15,214 shares of ePlus inc. common stock from an account owned by the reporting person to the Elaine D. Marion Trust for no consideration. The reporting person remains the beneficial owner of the securities held by the trust.

The shares are held in a revocable trust, of which the reporting person and her spouse are the sole trustees and beneficiaries.

On July 2, 2026, the reporting person transferred 15,488 shares of ePlus inc. common stock from an account owned by the reporting person to the Darren S. Raiguel Trust for no consideration. The reporting person remains the beneficial owner of the securities held by the trust.

The shares are held in a revocable trust, of which the reporting person and his spouse are the sole trustees and beneficiaries.

On July 1, 2026, the reporting person was issued 261 shares of common stock (the "Shares"). The Shares were issued pursuant to the reporting person's election to receive the Shares in lieu of cash compensation as permitted under the ePlus' 2024 Non-Employee Director Long Term Incentive Plan.

These shares were acquired under the ePlus inc. Employee Stock Purchase Plan in transactions that were exempt from Section 16(b) of the Exchange Act under SEC Exchange Act Rule 16b-3(c) and (d).

These shares were acquired under the ePlus inc. Employee Stock Purchase Plan in transactions that were exempt from Section 16(b) of the Exchange Act under SEC Exchange Act Rule 16b-3(c) and (d).

On June 15, 2026, the reporting person was granted a restricted stock award consisting of 16,247 shares of common stock of the Company (the "Restricted Shares"). The Restricted Shares were granted by the Compensation Committee, pursuant to the Plan. The Restricted Shares are subject to a restriction period, with one-third of the Restricted Shares vesting on each of March 18, 2027, March 16, 2028, and March 15, 2029. As more fully described in the Plan, under certain circumstances the restrictions may lapse, or the shares may be forfeited and transferred back to the Company.

On June 15, 2026, the reporting person was granted a restricted stock award consisting of 1,323 shares of common stock of the Company (the "Restricted Shares"). The Restricted Shares were granted by the Compensation Committee, pursuant to the Plan. The Restricted Shares are subject to a restriction period, with one-third of the Restricted Shares vesting on each of March 18, 2027, March 16, 2028, and March 15, 2029. As more fully described in the Plan, under certain circumstances the restrictions may lapse, or the shares may be forfeited and transferred back to the Company.

Represents shares of ePlus inc. (the "Company") common stock for performance share units ("PSUs") granted to the reporting person on June 15, 2026, under the 2021 Employee Long-Term Incentive Plan (the "Plan"). The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Compensation Committee of ePlus' Board of Directors (the "Compensation Committee").

Represents shares of ePlus inc. (the "Company") common stock for performance share units ("PSUs") granted to the reporting person on June 15, 2026, under the 2021 Employee Long-Term Incentive Plan (the "Plan"). The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Compensation Committee of ePlus' Board of Directors (the "Compensation Committee").